人工視網膜市場規模、佔有率、成長分析，按產品類型、按應用、按地區 - 按行業預測 - 2024-2031

2022年全球視網膜假體市場規模為52億美元，從2023年的64.8億美元成長到2031年的376.4億美元，年複合成長率預計將成長24.6%。

由於醫療技術的進步和視網膜疾病盛行率的上升，全球視網膜假體市場預計將大幅成長。視網膜假體（視網膜人工替代物）是一種創新設備，旨在幫助患有色素性視網膜炎和老齡化黃斑部病變等疾病的患者恢復視力。對有效治療的需求激增是由技術創新所推動的，這些技術創新增加了這些系統的功能，例如無線通訊和電極設計的改進。研發投資、政府措施和有利的報銷計畫進一步支持市場擴張。雖然北美在工業巨頭的支持和先進技術的引進下佔據市場主導地位，但由於醫療保健投資的增加和對視網膜健康問題認知的提高，亞太地區有望實現顯著成長。

目錄

介紹

• 研究目的
• 調查範圍
• 定義

調查方法

• 資訊採購
• 二手資料和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及前景

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 抑制因素和挑戰
• 波特分析與影響
  • 競爭公司之間的敵對關係
  • 替代品的威脅
  • 買方議價能力
  • 新進入者的威脅
  • 供應商的議價能力

主要市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2023）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 價格分析
• 技術進步
• 監管環境
• 案例研究

人工視網膜市場規模：依產品類型及年複合成長率（2024-2031）

• 市場概況
• 視網膜前植入
• 視網膜下植入
• 其他

人工視網膜市場規模：依應用與年複合成長率（2024-2031）

• 市場概況
• 老齡化黃斑部病變（AMD）
• 色素性視網膜炎

人工視網膜市場規模及年複合成長率（2024-2031）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 英國
  • 德國
  • 西班牙
  • 法國
  • 義大利
  • 歐洲其他地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中東/非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲

競爭資訊

• 前5名企業對比
• 主要企業市場定位（2023年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2023）
• 主要企業簡介
• 產品系列分析
• 按細分市場分類的佔有率分析
• 收益與前一年同期比較（2021-2023）

主要企業簡介

• Pixium Vision
• Axorus
• Intelligent Medical Implants
• LambdaVision, Inc.
• Nidek Co. Ltd.
• Nano Retina
• Bionic Vision Technologies
• Optobionics
• Medtronic
• Vivani Medical Inc.
• Labtician Ophthalmics, Inc.
• Retina Implant AG
• Altris, Inc.
• Second Sight Medical Applications, Inc.
• Neurotech Pharmaceuticals
• iBIONICS
• RenovaCare, Inc.
• Okuvision GmbH
• VisionCare, Inc.

結論和建議

Global Artificial Retina Market size was valued at USD 5.2 billion in 2022 and is poised to grow from USD 6.48 billion in 2023 to USD 37.64 billion by 2031, growing at a CAGR of 24.6% during the forecast period (2024-2031).

The global Artificial Retina Market is poised for remarkable growth due to advancements in medical technology and the rising incidence of retinal diseases. Artificial retinas, or retinal prostheses, are innovative devices aimed at restoring vision for those suffering from conditions like retinitis pigmentosa and age-related macular degeneration. This surge in demand for effective treatments is bolstered by technological innovations, including wireless communication and improved electrode designs, enhancing the functionality of these systems. Investments in R&D, government initiatives, and favorable reimbursement frameworks further drive market expansion. North America dominates the market, underpinned by major industry players and adoption of advanced technologies, while the Asia-Pacific region is set for significant growth due to increasing healthcare investments and awareness of retinal health issues.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Artificial Retina market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Artificial Retina Market Segmental Analysis

Global Artificial Retina Market is segmented by Product Type, Application, and region. Based on Product Type, the market is segmented into Epiretinal Implants, Subretinal Implants, and Others. Based on Application, the market is segmented into Age-Related Macular Degeneration (AMD), and Retinitis Pigmentosa. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Artificial Retina Market

A significant factor propelling the Global Artificial Retina Market is the rising incidence of retinal diseases. Conditions like retinitis pigmentosa, age-related macular degeneration, and diabetic retinopathy are becoming more common, driving demand for innovative artificial retina technologies. As the global population ages and the prevalence of chronic illnesses escalates, there is an increasing need for effective solutions to restore vision for those affected by retinal diseases. This urgent demand for advanced treatment options contributes to the overall growth and expansion of the artificial retina market, highlighting the critical role it plays in addressing these challenging health issues.

Restraints in the Global Artificial Retina Market

One significant limitation in the Global Artificial Retina market is the prohibitive cost associated with both the devices and the related procedures. The intricate and advanced technology involved in creating artificial retina systems, along with the substantial expenses tied to research, development, manufacturing, and obtaining regulatory approvals, leads to elevated pricing of these implants. This issue of affordability and accessibility hampers widespread adoption, particularly in areas where healthcare resources are scarce or where income levels are lower. As a result, the high costs present a considerable obstacle to market expansion, especially in developing regions and for patients facing financial constraints.

Market Trends of the Global Artificial Retina Market

The Global Artificial Retina Market is witnessing a significant trend towards miniaturization and integration of wireless communication technologies. As advancements in materials and engineering techniques progress, manufacturers are focusing on developing more compact, lightweight artificial retina devices that promise easier implantation and greater patient comfort. This movement is complemented by an emphasis on incorporating wireless features, enabling seamless data transfer and efficient remote monitoring, which paves the way for potential system upgrades and enhancements in functionality. This trend not only aims to enhance the user experience but also seeks to advance the clinical capabilities and overall effectiveness of artificial retina systems, driving innovation in the field.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement
• Regulatory Landscape
• Case Studies

Global Artificial Retina Market Size by Product Type & CAGR (2024-2031)

• Market Overview
• Epiretinal Implants
• Subretinal Implants
• Others

Global Artificial Retina Market Size by Application & CAGR (2024-2031)

• Market Overview
• Age-Related Macular Degeneration (AMD)
• Retinitis Pigmentosa

Global Artificial Retina Market Size & CAGR (2024-2031)

• North America, (Product Type, Application)
  • US
  • Canada
• Europe, (Product Type, Application)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific, (Product Type, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America, (Product Type, Application)
  • Brazil
  • Rest of Latin America
• Middle East & Africa, (Product Type, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Pixium Vision
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Axorus
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Intelligent Medical Implants
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LambdaVision, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nidek Co. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nano Retina
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bionic Vision Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Optobionics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vivani Medical Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Labtician Ophthalmics, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Retina Implant AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Altris, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Second Sight Medical Applications, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neurotech Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• iBIONICS
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• RenovaCare, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Okuvision GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• VisionCare, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation